Washington Trust CO Palatin Technologies Inc Transaction History

Washington Trust CO

  • $2.83 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 07, 2020
BUY
$0.36 - $0.79 $5,346 - $11,732
14,851 New
14,851 $6,000
Q4 2019

Feb 12, 2020
SELL
$0.75 - $0.89 $11,138 - $13,217
-14,851 Closed
0 $0
Q1 2019

May 13, 2019
BUY
$0.67 - $1.01 $3,250 - $4,899
4,851 Added 48.51%
14,851 $21,000
Q4 2017

Feb 05, 2018
BUY
$0.68 - $1.0 $6,800 - $10,000
10,000
10,000 $9,000

Others Institutions Holding PTN

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0
View Full List

About PALATIN TECHNOLOGIES INC

PTN Quotes by TradingView
  • Ticker PTN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,290,480
  • Market Cap $9.85M
  • Description
  • Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...
More about PTN
Track This Portfolio

Track Washington Trust CO Portfolio

Follow Washington Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email